Evidence map›Paper›PMID 28633626›Full record

Observational studyBMC geriatrics2017

Age-related differences in management and outcomes in hospitalized healthy and well-functioning bacteremic pneumococcal pneumonia patients: a cohort study.

Luis A Ruiz, Pedro P España, Ainhoa Gómez, Amaia Bilbao, Carmen Jaca, Amaia Arámburu, Alberto Capelastegui, Marcos I Restrepo, Rafael Zalacain

Abstract readObservational Study
In one paragraph

Observational study in BMC geriatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Observational
  9. Review
  10. Bloodstream infections in the elderly: what is the real goal?Aging clinical and experimental research · 2021
    Review
  11. Review
  12. Article
  13. Article
  14. Mortality and costs of pneumococcal pneumonia in adults: a cross-sectional study.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Luis A RuizPneumology Service, Hospital Universitario Cruces, E-48903, Barakaldo, Bizkaia, Spain. luisalberto.ruiziturriaga@osakidetza.eus.
Pedro P EspañaPneumology Service, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
Ainhoa GómezPneumology Service, Hospital Universitario Cruces, E-48903, Barakaldo, Bizkaia, Spain.
Amaia BilbaoResearch Unit, Hospital Universitario Basurto - Research Network on Health Services for Chronic Diseases (REDISSEC), Bilbao, Bizkaia, Spain.
Carmen JacaPneumology Service, Hospital Universitario Cruces, E-48903, Barakaldo, Bizkaia, Spain.
Amaia ArámburuPneumology Service, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
Alberto CapelasteguiPneumology Service, Hospital Galdakao-Usansolo, Galdakao, Bizkaia, Spain.
Marcos I RestrepoDivision Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System and University of Texas health Science Center, San Antonio, TX, USA.
Rafael ZalacainPneumology Service, Hospital Universitario Cruces, E-48903, Barakaldo, Bizkaia, Spain.

Funding

Effect of macrolides as immunomodulators in patients with sepsis and pneumoniaK23HL096054 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI RESTREPO, MARCOS I. · 2010 to 2014
$689k
NHLBI NIH HHS K23 HL096054
6 · The paper itself

Abstract

backgroundLimited data are available regarding fit and healthy patients with pneumonia at different ages. We evaluated the association of age with clinical presentation, serotype and outcomes among healthy and well-functioning patients hospitalized for bacteremic pneumococcal community-acquired pneumonia.

methodsWe performed a prospective cohort study of consecutive healthy and well-functioning patients hospitalized for this type of pneumonia. Patients were stratified into younger (18 to 64 years) and older (≥65 years) groups.

resultsDuring the study period, 399 consecutive patients were hospitalized with bacteremic pneumococcal pneumonia. We included 203 (50.8%) patients who were healthy and well-functioning patients, of whom 71 (35%) were classified as older. No differences were found in antibiotic treatment, treatment failure rate, antibiotic resistance, or serotype, except for serotype 7F that was less common in older patients. In the adjusted multivariate analysis, the older patients had higher 30-day mortality (OR 6.83; 95% CI 1.22-38.22; P = 0.028), but were less likely to be admitted to the ICU (OR 0.14; 95% CI 0.05-0.39; P < 0.001) and had shorter hospital stays (OR 0.71; 95% CI 0.54-0.94; P = 0.017).

conclusionsHealthy and well-functioning older patients have higher mortality than younger patients, but nevertheless, ICU admission was less likely and hospital stays were shorter. These results suggest that the aging process is a determinant of mortality, beyond the functional status of patients with bacteremic pneumococcal pneumonia.

Indexed as

Disease ManagementAdultAgedAged, 80 and overAge FactorsBacteremiaCohort StudiesCommunity-Acquired InfectionsFemaleHospitalizationHumansLength of StayMaleMiddle AgedPneumonia, PneumococcalProspective StudiesBacteremic pneumococcal pneumoniaCommunity-acquired pneumoniaPneumonia in older people

Identifiers

PMID28633626
PMCPMC5477680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.